Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial

Microarray patches (MAPs) have the potential to be a safer, more acceptable, easier-to-use, and more cost-effective means for the administration of vaccines than injection by needle and syringe. Here, we report findings from a randomized, partially double-blinded, placebo-controlled Phase I trial us...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Ben, Bermingham, Imogen M., Leelasena, Indika, Hickling, Julian, Young, Paul R., Muller, David A., Forster, Angus H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675090/
https://www.ncbi.nlm.nih.gov/pubmed/38006057
http://dx.doi.org/10.3390/vaccines11111725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675090/
https://www.ncbi.nlm.nih.gov/pubmed/38006057
http://dx.doi.org/10.3390/vaccines11111725

Ejemplares similares